NCT02075866

Brief Summary

Finnish Genetic Study for Arrhythmic Events (FinGesture is a prospective case-control study assessing the characteristics and genetic background of consecutive series of autopsy verified out-of-hospital victims of SCD vs. survivors of an acute coronary event in a specific geographical area in northern Finland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1998

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1998

Completed
16.2 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 3, 2014

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 4, 2014

Status Verified

March 1, 2014

Enrollment Period

19.9 years

First QC Date

February 27, 2014

Last Update Submit

March 3, 2014

Conditions

Sudden Cardiac DeathAcute Coronary Event

Outcome Measures

Primary Outcomes (1)

  • sudden cardiac death

    20 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive victims of sudden cardiac death verified by medicolegal autopsy (cases). Acute coronary event patients admitted to the Oulu University Hospital who survived to be discharged from the hospital (controls).

You may qualify if:

  • Sudden cardiac death verified by medicolegal autopsy (cases)
  • Acute coronary event (increased troponin levels/ECG markers of ischemia/angina pectoris; two out of three criteria) (controls).

You may not qualify if:

  • Sudden death due to other causes (cases).
  • Acute coronary event patients who died during hospitalization (controls).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oulu University Hospital

Oulu, 90014, Finland

RECRUITING

MeSH Terms

Conditions

Death, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Heart ArrestHeart DiseasesCardiovascular DiseasesDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Eeva Hookana, PhD

CONTACT

35883154464eeva.hookana@oulu.fi

Juhani Junttila, MD, PhD

CONTACT

358505444367juhani.junttila@oulu.fi

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2014

First Posted

March 3, 2014

Study Start

January 1, 1998

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

March 4, 2014

Record last verified: 2014-03

Locations

FI(1)